Role of bile acids in inflammatory liver diseases
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in the control of immune regulation and on effects of pharmacological modulators of bile acid signaling pathways in human liver disease. Recent mouse studies have highlighted the importance of the interactions between bile acids and gut microbiome. Interfering with microbiome composition may be beneficial for cholestatic and metabolic liver diseases by modulating formation of secondary bile acids, as different bile acid species have different signaling functions. Bile acid receptors such as FXR, VDR, and TGR5 are expressed in a variety of cells involved in innate as well as adaptive immunity, and specific microbial bile acid metabolites positively modulate immune responses of the host. Identification of Cyp2c70 as the enzyme responsible for the generation of hydrophilic mouse/rat-specific muricholic acids has allowed the generation of murine models with a human-like bile acid composition. These novel mouse models will aid to accelerate translational research on the (patho)physiological roles of bile acids in human liver diseases .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Their enterohepatic circulation allows them to act as hormones by stimulating nuclear receptors such as FXR in the gut and liver,40”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
Self-citationLoomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Cited by
Items 101–121 of 121
Heeren, J., Evangelakos, I., Verkade, E., Kuipers, F., Rohde, J. S., Heine, M., Worthmann, A., Graute, S., Fuh, M. M., Gunasekaran, K., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-8280795/v1
Self-citationMullapudi, T. R., Ravi, P. R., & Thipparapu, G. (2023) · Figshare · doi:10.6084/m9.figshare.24320010
Zhang, Q., Song, X., Khan, A., Shang, J., & Xue, J. (2025) · Current Microbiology · doi:10.1007/s00284-025-04664-6 · Cited by 1
Sidorina, A., Rizzo, C., Leal-Witt, M. J., Arias, C., Cortés, I., Cornejo, V., Sacchetti, E., Catesini, G., Boenzi, S., Dionisi‐Vici, C., et al. (2025) · Metabolites · doi:10.3390/metabo16010021
Attema, B. J., & Kuipers, F. (2026) · Engineering · doi:10.1016/j.eng.2026.01.002 · Cited by 1
Self-citationXu, J., Wan, W., Mu, H., Gong, S., Liu, Y., & Deng, T. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70813
Evangelakos, I., Verkade, E., Rohde, J. K., Zaufel, A., Vargek, M., Heine, M., Worthmann, A., Graute, S., Fuh, M. M., Gunasekaran, K., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102363
Self-citationInfluence of bile acids metabolism on hepatic immunity in mice
Guinot, V. (2022) · theses.fr (ABES) · doi:10.70675/b69bb11eza30fz4874z9af2za6e31b2d5ad8
Fuh, M. M., Hahn, J., Heine, M., Evangelakos, I., Scheja, L., Mann, O., Worthmann, A., Schlüter, H., & Heeren, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104572
Self-citationLanghans, B., Dold, L., Zhou, T., Trägner, J. S., Friedrichs, S., Stellaard, F., Lütjohann, D., Strassburg, C. P., & Kalthoff, S. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107059
Richter, F. C., Keszei, Z., Viczenczová, C., Baumgartner, M., Colaço, H. G., Siller, M., Holnsteiner, L., Baazim, H., Hofmann, A., Burrett, A., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.189882
Microbiome-Derived Effectors and Convergent Host Pathways in Organ Injury and Fibrosis
D'Alessandro, V., Fujimoto, H., D’Alessandro‐Gabazza, C. N., Toda, M., Shah, R., Nishihama, K., Hataji, O., Gabazza, E. C., Leckband, D. E., Cann, I., et al. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl51062
Qin, X., Huang, G., Han, Y., Zhou, M., Xu, M., Xiong, C., Liu, Y., Li, X., Chen, R., & Liang, F. (2026) · Medical Oncology · doi:10.1007/s12032-026-03332-4
Nazmul, M. H. M., Subramaniyan, V., Chakravarthi, S., Aung, T., Gupalo, S., Shwe, W. H., Devaraj, S., Htoo, P. M., Naing, M. M., Win, L. L., et al. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100731
Bi, Y., Song, W., Glymenaki, M., Hu, J., Li, X., Huang, H., Peng, Y., Ni, S., Haonon, O., Liu, Z., et al. (2026) · iMeta · doi:10.1002/imt2.70144 · Cited by 2
The Gut Microbiome as a Mechanistic Link Between the Planetary Health Diet and Healthy Aging
Jarecsny, T., Ceglédi, A., Csípő, T., Fazekas‐Pongor, V., Mózes, N., Csík, B., Zábó, V., Lipécz, Á., Nyáry, D., & Fekete, M. (2026) · Nutrients · doi:10.3390/nu18172864
Adu, M., Xia, B., Wang, Y., Hu, Y., Gao, Y., Sun, C., & Jiang, W. (2026) · Die Pharmazie · doi:10.31083/pharmazie53907
The gut-liver-brain axis in alcohol use disorder: The emerging role of bile acid dysregulation
Lin, X., Yu, X., Bai, X., Isha, H. M., Wang, C., Zhang, R., & Yang, F. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116487 · Cited by 1
Zhang, C., Zhang, Q., Zhang, L., Chen, Y., & Chen, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1925745
Huang, H., Zhang, J., Jin, J., Xie, Y., Pan, R., Zhao, M., Zhu, B., & Hua, J. (2026) · Toxics · doi:10.3390/toxics14100878
Chen, C., Jin, Y., Chen, W., Yuan, H., Hu, Y., & Hu, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1891550
Metadata
- Authors
- Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- University Medical Center Groningen (NL)
- Venue
- Seminars in Immunopathology
- Published
- 2021-07-08
- Volume
- 43
- Issue
- 4
- Pages
- 577-590
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- PMC
- PMC8443512
- OpenAlex
- W3179865180
- Cited by
- 121
- References
- 107
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 23 · 2023: 23 · 2022: 23 · 2021: 5
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Seminars in Immunopathology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB841)
- ICIN Netherlands Heart Institute (DCVA grant 2018-27)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- bile acids, bile acid signaling, inflammatory liver disease, cholestatic liver disease, metabolic liver disease, gut microbiota, secondary bile acids, farnesoid X receptor, vitamin D receptor, TGR5, immune regulation, muricholic acids, humanized mice, bile acid receptors
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bile Acids and Salts, Humans, Liver, Liver Diseases, Signal Transduction, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.